Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Alcaine
Active Ingredient: Proxymetacaine hydrochloride 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Alcon New Zealand Limited
Manufacturers: Alcon Laboratories Inc, Texas, United States of America
SA Alcon Couvreur NV, Puurs, Belgium
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 12th day of May 2011.
PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).